To leverage biological signalling via molecular based diagnostics & therapeutics in order to tackle cancer mortality.
Here’s how to reach us:
LD-CT + Liquid Biopsy
ctDNA as a Relapse Predictor
Possible GRAIL Product Integration
Our Plan
Revenue Opportunity